| Sign In to gain access to subscriptions and/or personal tools. |
Absence of β-Catenin Alteration in Hepatic Tumors Induced by p-Nitroanisole in Crj:BDF1 Mice
1 Department of Pathology, Osaka City University Medical School, Abeno-ku, Osaka 545-8585, Japan Correspondence: Address correspondence to: Shoji Fukushima, Department of Pathology, Osaka City University Medical School, 1-4-3, Asahi-machi, Abeno-ku, Osaka, Japan, 545-8585; e-mail:fukuchan{at}med.osaka-cu.ac.jp In the present study, β-catenin localization in hepatocellular neoplasms and hepatoblastomas, induced by oral administration of p-Nitroanisole (pNA) in Crj:BDF1 for 2 years, was evaluated by immunohistochemistry along with genetic alterations in exon 2 of β-catenin by the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) approach. Genomic DNA was isolated from paraffin sections of a total of 53 liver tumors. Immunohistochemical analysis revealed no abnormal accumulation of the β-catenin protein in any of the cases. No mutations (0/13), 20% silent mutations (3/15) and 8% silent plus 12% functional mutations (2 + 3/25), not in the multiple phosphorylation sites of β-catenin, were observed in hepatocellular adenomas, carcinomas and hepatoblastomas, respectively. The results indicate that β-catenin does not play an important role in development of hepatic tumors induced by pNA in Crj:BDF1 mice.
Key Words: β-Catenin alteration p-Nitroanisol carcinogenicity mouse liver tumors Abbreviations: pNA, p-Nitroanisole HCA, hepatocellular adenoma HCC, hepatocellular carcinoma HB, hepatoblastoma PCR-SSCP, polymerase chain reaction-single strand conformation polymorphism
Toxicologic Pathology, Vol. 34, No. 3,
237-242 (2006) |
|
|||

